Targeting a novel anti-platelet mechanism for improved anti-thrombotic therapy

靶向新型抗血小板机制以改善抗血栓治疗

• 批准号: nhmrc : 1144210
• 负责人: A/Pr Justin Hamilton
• 金额: $ 66.66万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/targeting-novel-anti-thrombotic-therapy/1320151
• 关键词: Targeting; novel; anti; platelet; mechanism

Blood clots cause heart attacks and most strokes, which are the most common cause of death in the world. Platelets are the cells in the blood that form these clots, and drugs that prevent platelet function are the major approach for heart attack and stroke prevention. However, many patients are resistant to the effects of existing therapies. These studies will develop a unique approach to prevent platelet function that may help overcome the limitations of current drugs.

血栓导致心脏病发作和大多数中风，这是世界上最常见的死亡原因。血小板是血液中形成这些凝块的细胞，阻止血小板功能的药物是预防心脏病发作和中风的主要方法。然而，许多患者对现有疗法的效果有抵抗力。这些研究将开发一种独特的方法来防止血小板功能，这可能有助于克服目前药物的局限性。